图书馆订阅: Guest
免疫学评论综述™

每年出版 6 

ISSN 打印: 1040-8401

ISSN 在线: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Tumor-Specific Immune Response: Current In Vitro Analyses May Not Reflect the In Vivo Immune Status

卷 18, 册 1-2, 1998, pp. 77-86
DOI: 10.1615/CritRevImmunol.v18.i1-2.90
Get accessGet access

摘要

Although our knowledge and understanding of tumor-specific cytotoxic T lymphocytes (CTL) have expanded considerably, the long-term work needed to assay CTL has precluded their analysis in large numbers of patients. Moreover, in vitro culture steps may introduce major biases. New approaches to identify tumor-specific CTL clones would be helpful. As a means to describe the in situ immune status by T-cell repertoire analysis, we developed the Immunoscope approach, a PCR-based method that allows us to determine the spectra of CDR3 lengths of the TCR chains displayed by complex populations of T cells. We review here some of our data about melanoma. Tumor-infiltrating lymphocytes of a melanoma patient were analyzed by different means and melanoma-specific T-cell clones were derived. Two categories of tumor-specific CD8+ CTL clones were derived from the infiltrate of a tumor-proximal invaded lymph node. The majority of T-cell clones specifically lyse the autologous tumor cell lines and predominantly recognize the HLA-A2/MART-127.35 peptide complex. The in vivo representativity of such CTL was assessed by the immunoscope technology. Among three MART- 1-specific clones, none was detectable in situ. The other kind of tumor-specific CD8+ CTL did not lyse autologous melanoma cell lines but lysed the “fresh” autologous tumor cells in a MHC class I dependent manner. The immunoscope approach revealed that one of the latter was detectable in situ among tumor-infiltrating lymphocytes although not among PBMC. These data indicate that melanoma-specific lymphocytes that could not have been selected through conventional screening procedures may be important in tumor rejection. Our results suggest that a better characterization of tumor-specific immune responses will be important for the optimization of specific immunotherapy strategies and the long-term follow-up of patients.

对本文的引用
  1. Belyakov Igor M., Wang Jian, Koka Rima, Ahlers Jeffrey D., Snyder James T., Tse Richard, Cox Josephine, Gibbs James S., Margulies David H., Berzofsky Jay A., Activating CTL precursors to reveal CTL function without skewing the repertoire byin vitro expansion, European Journal of Immunology, 31, 12, 2001. Crossref

  2. Vetter Claudia S., Terheyden Patrick, Bröcker Eva-B, Becker Jürgen C., Straten Perthor, Zeuthen Jesper, Expression of CD94/NKG2 Subtypes on Tumor-Infiltrating Lymphocytes in Primary and Metastatic Melanoma, Journal of Investigative Dermatology, 114, 5, 2000. Crossref

  3. Shafer-Weaver Kimberly, Rosenberg Steven, Strobl Susan, Gregory Alvord W., Baseler Michael, Malyguine Anatoli, Application of the Granzyme B ELISPOT Assay for Monitoring Cancer Vaccine Trials, Journal of Immunotherapy, 29, 3, 2006. Crossref

  4. Pedersen Lars Østergaard, Vetter Claudia S., Mingari Maria C., Andersen Mads Hald, thor Straten Per, Bröcker Eva-B, Becker Jürgen C., Differential Expression of Inhibitory or Activating CD94/NKG2 Subtypes on MART-1-Reactive T Cells in Vitiligo Versus Melanoma: A Case Report, Journal of Investigative Dermatology, 118, 4, 2002. Crossref

  5. Turatti Fabio, Figini Mariangela, Alberti Paola, Willemsen Ralph A., Canevari Silvana, Mezzanzanica Delia, Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor, The Journal of Gene Medicine, 7, 2, 2005. Crossref

  6. Letsch Anne, Keilholz Ulrich, Schadendorf Dirk, Nagorsen Dirk, Schmittel Alexander, Thiel Eckhard, Scheibenbogen Carmen, High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma, International Journal of Cancer, 87, 5, 2000. Crossref

  7. Straten Per thor, Guldberg Per, Moerch Ulrik, Becker Jürgen C., Anti-Melanocyte T Cell Responses – Methodology Versus Biology, Journal of Investigative Dermatology, 114, 4, 2000. Crossref

  8. Cochlovius Bj�rn, Linnebacher Michael, Zewe-Welschof Monika, Z�ller Margot, Recombinant gp100 protein presented by dendritic cells elicits a T-helper-cell responsein vitro andin vivo, International Journal of Cancer, 83, 4, 1999. Crossref

  9. Musette Philippe, Bachelez Hervé, Kourilsky Philippe, Dubertret Louis, Gachelin Gabriel, What is the Best Way to Define the Antimelanocyte T Cell Repertoire?, Journal of Investigative Dermatology, 113, 2, 1999. Crossref

  10. Mosca Paul J., Hobeika Amy C., Clay Timothy M., Morse Michael A., Lyerly H.Kim, Direct detection of cellular immune responses to cancer vaccines, Surgery, 129, 3, 2001. Crossref

  11. Sogn John A, Tumor Immunology, Immunity, 9, 6, 1998. Crossref

  12. Renard Isabelle, Mezzanzanica Delia, Canevari Silvana, Ferrini Silvano, Boniver Jacques, Delvenne Philippe, Jacobs Nathalie, Anti-CD3/Anti-Epidermal Growth Factor Receptor-Bispecific Antibody Retargeting of Lymphocytes against Human Neoplastic Keratinocytes in an Autologous Organotypic Culture Model, The American Journal of Pathology, 160, 1, 2002. Crossref

  13. Joncker Nathalie T., Marloie Marie-Annick, Chernysheva Anna, Lonchay Christophe, Cuff Simone, Klijanienko Jerzy, Sigal-Zafrani Brigitte, Vincent-Salomon Anne, Sastre Xavier, Lantz Olivier, Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors, International Journal of Cancer, 118, 5, 2006. Crossref

  14. thor Straten Per, Kirkin Alexei F., Siim Elsebeth, Dahlström Karin, Drzewiecki Krzysztof T., Seremet Tina, Zeuthen Jesper, Becker Jürgen C., Guldberg Per, Tumor Infiltrating Lymphocytes in Melanoma Comprise High Numbers of T-Cell Clonotypes That Are Lost during in Vitro Culture, Clinical Immunology, 96, 2, 2000. Crossref

  15. Lim Annick, Baron Véronique, Ferradini Laurent, Bonneville Marc, Kourilsky Philippe, Pannetier Christophe, Combination of MHC–peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses, Journal of Immunological Methods, 261, 1-2, 2002. Crossref

  16. Pittet Mikaël J., Valmori Danila, Dunbar P. Rod, Speiser Daniel E., Liénard Danielle, Lejeune Ferdy, Fleischhauer Katharina, Cerundolo Vincenzo, Cerottini Jean-Charles, Romero Pedro, High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals, Journal of Experimental Medicine, 190, 5, 1999. Crossref

  17. Cho Eun Kyung, Kim Mihyang, A red algal cyclophilin has an effect on development and growth in Nicotiana tabacum, Plant Physiology and Biochemistry, 46, 10, 2008. Crossref

  18. Becker Jürgen C., Guldberg Per, Zeuthen Jesper, Bröcker Eva-Bettina, Straten Per thor, Accumulation of Identical T Cells in Melanoma and Vitiligo-Like Leukoderma, Journal of Investigative Dermatology, 113, 6, 1999. Crossref

  19. Shao Hongwei, Lin Yanmei, Wang Teng, Ou Yusheng, Shen Han, Tao Changli, Wu Fenglin, Zhang Wenfeng, Bo Huaben, Wang Hui, Huang Shulin, Identification of peptide-specific TCR genes by in vitro peptide stimulation and CDR3 length polymorphism analysis, Cancer Letters, 363, 1, 2015. Crossref

  20. De Amici M., Mosca M., Vignini M., Quaglini S., Moratti R., Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen, Annals of Allergy, Asthma & Immunology, 91, 5, 2003. Crossref

  21. Sánchez-Ramón Silvia, Faure Florence, Through the Immune Looking Glass: A Model for Brain Memory Strategies, Frontiers in Cellular Neuroscience, 10, 2016. Crossref

  22. Blattman Joseph N., Sourdive David J. D., Murali-Krishna Kaja, Ahmed Rafi, Altman John D., Evolution of the T Cell Repertoire During Primary, Memory, and Recall Responses to Viral Infection, The Journal of Immunology, 165, 11, 2000. Crossref

  23. Malyguine Anatoli, Strobl Susan, Zaritskaya Liubov, Baseler Michael, Shafer-Weaver Kimberly, New Approaches for Monitoring CTL Activity in Clinical Trials, in Immune-Mediated Diseases, 601, 2007. Crossref

  24. Beatty Gregory L., Paterson Yvonne, IFN-γ Can Promote Tumor Evasion of the Immune System In Vivo by Down-Regulating Cellular Levels of an Endogenous Tumor Antigen, The Journal of Immunology, 165, 10, 2000. Crossref

  25. Komita H, Zhao X, Katakam A K, Kumar P, Kawabe M, Okada H, Braughler J M, Storkus W J, Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity, Cancer Gene Therapy, 16, 12, 2009. Crossref

  26. Herr Wolfgang, Ranieri Elena, Gambotto Andrea, Kierstead Lisa Salvucci, Amoscato Andrew A., Gesualdo Loreto, Storkus Walter J., Identification of naturally processed and HLA-presented Epstein–Barr virus peptides recognized by CD4 + or CD8 + T lymphocytes from human blood , Proceedings of the National Academy of Sciences, 96, 21, 1999. Crossref

  27. thor Straten Per, Guldberg Per, Seremet Tina, Reisfeld Ralph A., Zeuthen Jesper, Becker Jürgen C., Activation of preexisting T cell clones by targeted interleukin 2 therapy, Proceedings of the National Academy of Sciences, 95, 15, 1998. Crossref

  28. Dharmadhikari Neal, Mehnert Janice M., Kaufman Howard L., Oncolytic Virus Immunotherapy for Melanoma, Current Treatment Options in Oncology, 16, 3, 2015. Crossref

将发表的论文

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain